Discordance between peritumoral and subareolar injections for mapping sentinel lymph nodes in the breast
Breast Cancer Research and Treatment · 2025
DOI: 10.1007/s10549-024-07491-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2025. Verfasst von Josephine Situ und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Engineering Science, The University of Auckland, Auckland, New Zealand. Hauptthemen laut MEDLINE: Breast Neoplasms, Sentinel Lymph Node, Sentinel Lymph Node Biopsy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Council of New Zealand, University of Auckland.
Abstract (Originalsprache)
Purpose
Sentinel node biopsy (SNB) is a common staging tool for breast cancer. Initially, peritumoral (PT) injections were used, however subareolar (SA) injections were later introduced to simplify the technique. Controversy remains regarding whether PT and SA injections map the same sentinel lymph nodes (SLNs). This study aimed to determine whether the regional location of breast SLNs differs when using PT versus SA injections using a large dataset from a single institution.
Methods
A total of 1035 patients who underwent breast SNB (PT injections: n = 858 and SA injections: n = 177) with lymphoscintigraphy and SPECT/CT were included. The identified SLN locations using SA injections were compared with those using PT injections. Differences in drainage proportions and odds ratios (ORs) for each clockface breast region and the whole breast were calculated using a two-proportion z-test and Fisher’s Exact Test.
Results
A higher proportion of internal mammary SLNs were identified using PT injections for the whole breast (0.30 versus 0.09) and for all breast regions, with all regions showing statistical significance except the upper outer quadrant. Similarly, ORs showed identification of internal mammary SLNs was significantly higher when using PT injections (4.35, 95% CI 2.53 to 7.95). There were no significant differences in identifying axillary SLNs between injection sites.
Conclusion
This is the largest cohort study to compare the regional location of breast SLNs identified using PT injections versus SA injections. Discordance was shown in the SLNs identified between injection techniques, with PT injections more frequently identifying internal mammary SLNs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Engineering Science, The University of Auckland, Auckland, New Zealand.
- Auckland Bioengineering Institute, The University of Auckland, Auckland, New Zealand.
- Australian Lymphoedema Education Research and Treatment Program (ALERT), Department of Health Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.
- Alfred Nuclear Medicine and Ultrasound, Newtown, NSW, Australia.
- Discipline of Child and Adolescent Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
- Auckland Bioengineering Institute, The University of Auckland, Auckland, New Zealand. Hayley.Reynolds@auckland.ac.nz.
Förderung
- Health Research Council of New Zealand
- University of Auckland
Zitieren
APA
Situ, J., Walker, C., Jayathungage Don, T. D., Suami, H., Chung, D. K. V., & Reynolds, H. M. (2025). Discordance between peritumoral and subareolar injections for mapping sentinel lymph nodes in the breast. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07491-8
Vancouver
Situ J, Walker C, Jayathungage Don TD, Suami H, Chung DKV, Reynolds HM. Discordance between peritumoral and subareolar injections for mapping sentinel lymph nodes in the breast. Breast Cancer Research and Treatment. 2025. doi:10.1007/s10549-024-07491-8
BibTeX
@article{Situ2025,
author = {Situ, Josephine and Walker, Cameron and Jayathungage Don, Tharanga D and Suami, Hiroo and Chung, David K V and Reynolds, Hayley M},
title = {Discordance between peritumoral and subareolar injections for mapping sentinel lymph nodes in the breast},
journal = {Breast Cancer Research and Treatment},
year = {2025},
doi = {10.1007/s10549-024-07491-8}
}
EUVIMED